AlloMend Acellular Dermal Matrix (ADM) Allograft

· AlloSource

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AlloMend Acellular Dermal Matrix (ADM) Allograft, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction